Kanako Shimizu

5.1k citations
70 papers · 4.0k indexed · 2 hit papers · h-index 31
  • Immunology top 0.5%
    • Immune Cell Function and Interaction 51
    • Immunotherapy and Immune Responses 45
    • T-cell and B-cell Immunology 31
    • Immune cells in cancer 4
  • Oncology top 1%
    • CAR-T cell therapy research 26
    • Cancer Immunotherapy and Biomarkers 6
  • Hematology top 5%
    • Hematopoietic Stem Cell Transplantation 3
  • Virology top 10%
    • SARS-CoV-2 and COVID-19 Research 3

Kanako Shimizu

70 papers receiving 3.9k citations

Hit Papers

Activation of Natural Killer T Cells by α-Galactosylceram...5972002202620102018100200300400500

Peers

Kanako Shimizu
Comparison fields: 5 of 102
  • Immunology 3.3k
  • Oncology 1.8k
  • Hematology 263
  • Molecular Biology 742
  • Virology 35
Replace Thomas Berger with:
Thomas Berger Germany
Anne Caignard France
Peter A. Savage United States
Detlef Dieckmann Germany
Nicolai Wagtmann United States
Saskia J. Santegoets Netherlands
Jennifer L. Matsuda United States
C. Marcela Díaz‐Montero United States
Petra Keikavoussi Germany
Gernot Stuhler Germany
Kanako Shimizu relative to Thomas Berger Germany Thomas Berger's profile →
Citations per field
00.5×6.9×
Thomas Berger · 1×
Citations per year

Countries citing papers authored by Kanako Shimizu

Since Specialization
Citations

This map shows the geographic impact of Kanako Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanako Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanako Shimizu more than expected).

Fields of papers citing papers by Kanako Shimizu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kanako Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanako Shimizu. The network helps show where Kanako Shimizu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kanako Shimizu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kanako Shimizu Line = papers co-authored together Kanako Shimizu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20233
2 202313
3 20232
4 20234
5 20237
6 202213
7 202022
8 202050
9 201933
10 201814
11 2016101
12 201633
13 201232
14 20107
15 200930
16 200915
17 200812
18 200786
19 200629
20 2003331

About Kanako Shimizu

Kanako Shimizu is a scholar working on Immunology, Oncology and Hematology, having authored 70 papers that have together received 4.0k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (51 papers), Immunotherapy and Immune Responses (45 papers), T-cell and B-cell Immunology (31 papers), CAR-T cell therapy research (26 papers), Cancer Immunotherapy and Biomarkers (6 papers), Immune cells in cancer (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). The work is most often cited by research in Immunology (3.3k citations), Oncology (1.8k citations) and Hematology (263 citations). Kanako Shimizu has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Shin‐ichiro Fujii, Ralph M. Steinman, C. Smith, Laura C. Bonifaz, Mitchell Kronenberg, Madhav V. Dhodapkar, Masaru Taniguchi, Matthew D. Geller, Satoru Yamasaki and Hiroaki Hemmi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026